Top Story

CheckMate-040: Opdivo may present an option for Child-Pugh B HCC

November 13, 2018
Meeting News

DAAs reduce HCC, decompensation risk compared with no treatment

November 12, 2018
SAN FRANCISCO — Individuals with hepatitis C who underwent DAA therapy experienced significant reductions in both hepatocellular carcinoma and decompensation risk…
Meeting News

Healio to report live from The Liver Meeting 2018

November 10, 2018
SAN FRANCISCO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage from The Liver Meeting 2018. The meeting will feature…
FDA News

FDA approves Keytruda for patients with previously treated hepatocellular carcinoma

November 10, 2018
The FDA granted accelerated approval to pembrolizumab for the treatment of patients with hepatocellular carcinoma who received prior sorafenib. The approval is the 14th…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 20: A 58-Year-Old Female Underwent A Screening Colonoscopy That Showed A 2.5-Cm Flat Polyp In The Proximal Ascending Colon. I Tattooed The Area And Biopsied The Polyp, Which Was Initially Reported As Hyperplastic. What Should I Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

Exact Sciences expands noninvasive cancer testing in the GI space

June 11, 2018
More »